Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Kostikas

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
Respirology (Carlton, Vic.)|April 23, 2019
Letter from GreeceKonstantinos Kostikas
Respirology (Carlton, Vic.)|April 16, 2021
Letter from GreeceKonstantinos Kostikas
COPD|February 24, 2025
Biologics in COPD: The Road is Still Long and WindingKonstantinos Kostikas, Athena Gogali
The European Respiratory Journal|May 19, 2023
Latent COPD: a proposed new term in the disease nomenclatureAthena Gogali, Konstantinos Kostikas
Medicina Clinica (English Ed.)|February 1, 2021
Lactate dehydrogenase, COVID-19 and mortalityKonstantinos Bartziokas, Konstantinos Kostikas
BMC Pulmonary Medicine|September 17, 2010
"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPDKonstantinos Kostikas, Demosthenes Bouros
Lung|November 12, 2025
Biologics in COPD: Do We Need a Divide and Conquer Approach?Athena Gogali, Konstantinos Kostikas
Postgraduate Medical Journal|March 2, 2022
Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?Haralampos Milionis, Konstantinos Kostikas
Medicina Clinica|November 10, 2020
[Lactate dehydrogenase, COVID-19 and mortality]Konstantinos Bartziokas, Konstantinos Kostikas
COPD|April 27, 2016
Does the Term "Deflators" Reflect More Accurately the Beneficial Effects of Long-acting Bronchodilators in COPD?Konstantinos Kostikas, Nikolaos M Siafakas
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
Respirology (Carlton, Vic.)|April 23, 2019
Letter from GreeceKonstantinos Kostikas
Respirology (Carlton, Vic.)|April 16, 2021
Letter from GreeceKonstantinos Kostikas
COPD|February 24, 2025
Biologics in COPD: The Road is Still Long and WindingKonstantinos Kostikas, Athena Gogali
The European Respiratory Journal|May 19, 2023
Latent COPD: a proposed new term in the disease nomenclatureAthena Gogali, Konstantinos Kostikas
Medicina Clinica (English Ed.)|February 1, 2021
Lactate dehydrogenase, COVID-19 and mortalityKonstantinos Bartziokas, Konstantinos Kostikas
BMC Pulmonary Medicine|September 17, 2010
"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPDKonstantinos Kostikas, Demosthenes Bouros
Lung|November 12, 2025
Biologics in COPD: Do We Need a Divide and Conquer Approach?Athena Gogali, Konstantinos Kostikas
Postgraduate Medical Journal|March 2, 2022
Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?Haralampos Milionis, Konstantinos Kostikas
Medicina Clinica|November 10, 2020
[Lactate dehydrogenase, COVID-19 and mortality]Konstantinos Bartziokas, Konstantinos Kostikas
COPD|April 27, 2016
Does the Term "Deflators" Reflect More Accurately the Beneficial Effects of Long-acting Bronchodilators in COPD?Konstantinos Kostikas, Nikolaos M Siafakas
Pageof 30